BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

288 related articles for article (PubMed ID: 35057459)

  • 21. Proteolysis and Process-Induced Modifications in Synbiotic Yogurt Investigated by Peptidomics and Phosphopeptidomics.
    Pinto G; Picariello G; Addeo F; Chianese L; Scaloni A; Caira S
    J Agric Food Chem; 2020 Aug; 68(32):8744-8754. PubMed ID: 32678598
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hydroxysafflor yellow A exerts beneficial effects by restoring hormone secretion and alleviating oxidative stress in polycystic ovary syndrome mice.
    Luo M; Huang JC; Yang ZQ; Wang YS; Guo B; Yue ZP
    Exp Physiol; 2020 Feb; 105(2):282-292. PubMed ID: 31803965
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Androgen-induced gut dysbiosis disrupts glucolipid metabolism and endocrinal functions in polycystic ovary syndrome.
    Han Q; Wang J; Li W; Chen ZJ; Du Y
    Microbiome; 2021 May; 9(1):101. PubMed ID: 33957990
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Daily consumption of a synbiotic yogurt decreases energy intake but does not improve gastrointestinal transit time: a double-blind, randomized, crossover study in healthy adults.
    Tulk HM; Blonski DC; Murch LA; Duncan AM; Wright AJ
    Nutr J; 2013 Jun; 12():87. PubMed ID: 23787118
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dehydroepiandrosterone-induced polycystic ovary syndrome mouse model requires continous treatments to maintain reproductive phenotypes.
    Wu H; Zhao B; Yao Q; Kang J
    J Ovarian Res; 2023 Oct; 16(1):207. PubMed ID: 37880784
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Participation of the intestinal microbiota in the mechanism of beneficial effect of treatment with synbiotic Syngut on experimental colitis under stress conditions.
    Konturek PC; Konturek K; Brzozowski T; Wojcik D; Magierowski M; Targosz A; Krzysiek-Maczka G; Sliwowski Z; Strzalka M; Magierowska K; Szczyrk U; Kwiecien S; Ptak-Belowska A; Neurath M; Dieterich W; Wirtz S; Zopf Y
    J Physiol Pharmacol; 2020 Jun; 71(3):. PubMed ID: 32991312
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A New Approach to Polycystic Ovary Syndrome: The Gut Microbiota.
    Yurtdaş G; Akdevelioğlu Y
    J Am Coll Nutr; 2020; 39(4):371-382. PubMed ID: 31513473
    [TBL] [Abstract][Full Text] [Related]  

  • 28. High-Fiber Diet or Combined With Acarbose Alleviates Heterogeneous Phenotypes of Polycystic Ovary Syndrome by Regulating Gut Microbiota.
    Wang X; Xu T; Liu R; Wu G; Gu L; Zhang Y; Zhang F; Fu H; Ling Y; Wei X; Luo Y; Shen J; Zhao L; Peng Y; Zhang C; Ding X
    Front Endocrinol (Lausanne); 2021; 12():806331. PubMed ID: 35185786
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Gut microbiota alterations reveal potential gut-brain axis changes in polycystic ovary syndrome.
    Liang Z; Di N; Li L; Yang D
    J Endocrinol Invest; 2021 Aug; 44(8):1727-1737. PubMed ID: 33387350
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Unraveling intestinal microbiota's dominance in polycystic ovary syndrome pathogenesis over vaginal microbiota.
    Yu X; Li X; Yang H
    Front Cell Infect Microbiol; 2024; 14():1364097. PubMed ID: 38606298
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Tempol ameliorates polycystic ovary syndrome through attenuating intestinal oxidative stress and modulating of gut microbiota composition-serum metabolites interaction.
    Li T; Zhang T; Gao H; Liu R; Gu M; Yang Y; Cui T; Lu Z; Yin C
    Redox Biol; 2021 May; 41():101886. PubMed ID: 33592539
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Astragalus polysaccharide alleviates polycystic ovary syndrome by reducing insulin resistance and oxidative stress and increasing the diversity of gut microbiota.
    Li R; Hu R; Huang Y; Li D; Ma X; Yang Y
    Endocrine; 2024 Mar; 83(3):783-797. PubMed ID: 37824046
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of Yulin Tong Bu formula on modulating gut microbiota and fecal metabolite interactions in mice with polycystic ovary syndrome.
    Su YN; Wang MJ; Yang JP; Wu XL; Xia M; Bao MH; Ding YB; Feng Q; Fu LJ
    Front Endocrinol (Lausanne); 2023; 14():1122709. PubMed ID: 36814581
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The effects of synbiotic supplementation on hormonal status, biomarkers of inflammation and oxidative stress in subjects with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial.
    Nasri K; Jamilian M; Rahmani E; Bahmani F; Tajabadi-Ebrahimi M; Asemi Z
    BMC Endocr Disord; 2018 Apr; 18(1):21. PubMed ID: 29649996
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Anxiogenic effects of a Lactobacillus, inulin and the synbiotic on healthy juvenile rats.
    Barrera-Bugueño C; Realini O; Escobar-Luna J; Sotomayor-Zárate R; Gotteland M; Julio-Pieper M; Bravo JA
    Neuroscience; 2017 Sep; 359():18-29. PubMed ID: 28694176
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Immune status, well-being and gut microbiota in military supplemented with synbiotic ice cream and submitted to field training: a randomised clinical trial.
    Valle MCPR; Vieira IA; Fino LC; Gallina DA; Esteves AM; da Cunha DT; Cabral L; Benatti FB; Marostica Junior MR; Batista ÂG; Santos R; Pastore GM; Sartoratto A; Sivieri K; Tizioto PC; Coutinho LL; Antunes AEC
    Br J Nutr; 2021 Dec; 126(12):1794-1808. PubMed ID: 33593462
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Naringenin regulates gut microbiota and SIRT1/ PGC-1ɑ signaling pathway in rats with letrozole-induced polycystic ovary syndrome.
    Wu YX; Yang XY; Han BS; Hu YY; An T; Lv BH; Lian J; Wang TY; Bao XL; Gao L; Jiang GJ
    Biomed Pharmacother; 2022 Sep; 153():113286. PubMed ID: 35724506
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A synbiotic formulation of
    Wang C; Chen W; Jiang Y; Xiao X; Zou Q; Liang J; Zhao Y; Wang Q; Yuan T; Guo R; Liu X; Liu Z
    Food Funct; 2024 Jan; 15(1):387-400. PubMed ID: 38099485
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of oral administration of low-dose follicle stimulating hormone on hyperandrogenized mice as a model of polycystic ovary syndrome.
    Tessaro I; Modina SC; Franciosi F; Sivelli G; Terzaghi L; Lodde V; Luciano AM
    J Ovarian Res; 2015 Oct; 8():64. PubMed ID: 26437930
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The ameliorative effects of marjoram in dehydroepiandrosterone induced polycystic ovary syndrome in rats.
    Rababa'h AM; Matani BR; Ababneh MA
    Life Sci; 2020 Nov; 261():118353. PubMed ID: 32877649
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.